Erratum: Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combinedwith S-1 for locally advanced rectal cancer (Journal of Radiation Research (2014) 55 (10.1093/jrr/rrt058));Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer

Journal of Radiation Research

Volumn 54, Issue 6, 2013, Pages 1118-1124

  Doi, Hiroshi ^a   Beppu, Naohito ^b   Odawara, Soichi ^a   Tanooka, Masao ^a   Takada, Yasuhiro ^a   Niwa, Yasue ^a   Fujiwara, Masayuki ^a   Kimura, Fumihiko ^b   Yanagi, Hidenori ^b   Yamanaka, Naoki ^b   Kamikonya, Norihiko ^a   Hirota, Shozo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Meiwa Hospital   (Japan)

Author keywords

Accelerated hyperfractionated radiotherapy; Preoperative radiotherapy; Radiotherapy; Rectal cancer; S 1; Short course radiotherapy

Indexed keywords

CHEMOTHERAPY; DISEASE CONTROL; RADIOTHERAPY; SURGERY;

ACCELERATED HYPERFRACTIONATED RADIOTHERAPY; HYPERFRACTIONATED ACCELERATED RADIOTHERAPIES; HYPERFRACTIONATED RADIOTHERAPIES; LOCALLY ADVANCED RECTAL CANCERS; PREOPERATIVE RADIOTHERAPY; RADICAL SURGERY; RECTAL CANCER; S-1; SHORT COURSE; SHORT-COURSE RADIOTHERAPY;

DISEASES;

ABDOMINAL SURGERY; ACCELERATED HYPERFRACTIONATED RADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; PREOPERATIVE RADIOTHERAPY; PREVALENCE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RECTUM CANCER; RECTUM TUMOR; RISK FACTOR; S-1; SHORT-COURSE RADIOTHERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

ACCELERATED HYPERFRACTIONATED RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RADIOTHERAPY; RECTAL CANCER; S-1; SHORT-COURSE RADIOTHERAPY;

ADULT; AGED; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PREVALENCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84888270558     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rru068     Document Type: Erratum

References (26)

1. Marijnen CA, Glimelius B. The role of radiotherapy in rectal cancer. Eur J Cancer 2002;38:943-52
2. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40
3. Ngan SY, Burmeister B, Fisher RJ et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012;30:3827-33
4. Frykholm GJ, Isacsson U, Nygård K et al. Preoperative radiotherapy in rectal carcinoma - aspects of acute adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996;35:1039-48
5. Myerson RJ, Garofalo MC, El Naqa I et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiationtherapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009;74:824-30
6. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-23
7. Guckenberger M, Saur G, Wehner D et al. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 2012;188:551-7
8. Guckenberger M, Wulf J, Thalheimer A et al. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total doseof 29 Gy-long-term results. Radiat Oncol 2009;4:67
9. Ceelen W, Boterberg T, Pattyn P et al. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2007;14:424-31
10. Marsh RW, George TJ, Siddiqui T et al. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer. Am J Clin Oncol 2010;33:251-6
11. Liszka L, Zielińska-Pajak E, Pajak J et al. Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol 2007;13:515-24
12. Widder J, Herbst F, Dobrowsky W et al. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase 2). Br J Cancer 2005;92:1209-14
13. Brooks S, Glynne-Jones R, Novell R et al. Short-course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer. Acta Oncol 2006;45:1079-85
14. Coucke PA, Notter M, Matter M et al. Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): is it a matter of days? Acta Oncol 2006;45:1086-93
15. Das P, Delclos ME, Skibber JM et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 2010;77:60-5
16. Ceelen W, Fierens K, Van Nieuwenhove Y et al. Preoperative chemoradiation versus radiation alone for stage II and III respectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 2009;124:2966-72
17. Nakata E, Fukushima M, Takai Y et al. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. Oncol Rep 2006;16:465-71
18. Sadahiro S, Suzuki T, Tanaka A et al. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma. Oncology 2011;81:306-11
19. Wada H, Nemoto K, Nomiya T et al. A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrentrectal cancer. Int J Clin Oncol 2013;18:273-8
20. Morimoto S, Shimada M, Kurita N et al. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer:phase 1 trial. Hepatogastroenterology 2012;59:1428-32
21. Kusunoki M, Shoji Y, Yanagi H et al. Modified anoabdominal rectal resection and colonic J-pouch anal anastomosis for lower rectal carcinoma: preliminary report. Surgery 1992;112: 876-83
22. Peeters KC, van de Velde CJ, Leer JW et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - a Dutch colorectal cancer group study. J Clin Oncol 2005;23:6199-206
23. Viani GA, Stefano EJ, Soares FV et al. Evaluation of biologic effective dose and schedule of fractionation for preoperative radiotherapy for rectal cancer: meta-analyses and metaregression. Int J Radiat Oncol Biol Phys 2011;80:985-91
24. Enríquez-Navascués JM, Borda N, Lizerazu A et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 2011;17:1674-84
25. Pettersson D, Holm T, Iversen H et al. Preoperative shortcourse radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 2012;99:577-83
26. Lange MM, Maas CP, Marijnen CA et al. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 2008;95:1020-8